Aurobindo Pharma gains on receiving USFDA approval for Metronidazole Tablets USP

02 Jun 2015 Evaluate

Aurobindo Pharma is currently trading at Rs. 1378.40, up by 16.85 points or 1.24% from its previous closing of Rs. 1361.55 on the BSE.

The scrip opened at Rs. 1376.00 and has touched a high and low of Rs. 1382.00 and Rs. 1373.95 respectively. So far 3,407 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1432.10 on 17-Apr-2015 and a 52 week low of Rs. 619.85 on 03-Jun-2014.

Last one week high and low of the scrip stood at Rs. 1395.00 and Rs. 1292.45 respectively. The current market cap of the company is Rs. 40,246.00 crore.

The promoters holding in the company stood at 53.97% while Institutions and Non-Institutions held 35.82% and 10.21% respectively.

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Metronidazole Tablets USP 250mg and 500mg (ANDA 203974). The company will commence shipping shortly. The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Flagyl Tablets, 250mg and 500mg of GD Searle LLC.

Metronidazole Tablets are used to treat different types of infections which are due to particular types of bacteria and some other infectious organisms, or to prevent infection during an operation. The product has an estimated market size of $58 Million for the twelve months ending March 2015 according to IMS.

This is the 37th ANDA to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing Oral Non-betalactam products. Aurobindo now has a total of 194 ANDA approvals (167 Final approvals including 9 from Aurolife Pharma LLC and 27 Tentative approvals) from USFDA.


Aurobindo Pharma Share Price

1117.00 -16.15 (-1.43%)
27-Jan-2026 14:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1624.95
Dr. Reddys Lab 1235.30
Cipla 1314.60
Zydus Lifesciences 887.35
Lupin 2125.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×